Today's Updates

Optimizing Care Transitions and Referral Decision-Making Across the HNSCC Continuum
Published Date: 24 Sep 2026

Optimizing Care Transitions and Referral Decision-Making Across the HNSCC Continuum

Read More
Liver Failure or Liver Mets?
Published Date: 24 Sep 2026

Diagnosis complicated by absence of radiologic evidence of hepatic lesions

Read More
Here's Why Hematuria in a Young Patient Should Always Be Investigated
Published Date: 24 Sep 2026

Terminology also makes a difference

Read More

Latest News

Shingles Recurrence or Something Worse?

Bedside skin punch biopsy proved crucial

Skin Problems, Kidney Complaints, and Venous Issues Spike During Heat Waves

Study suggests attention to heat-related problems besides heat stroke

First Oral Option for Dermatomyositis Gets FDA Green Light

Brepocitinib significantly improved overall symptom status in a phase III trial

A Call to End Routine Laboratory Monitoring for Patients on Isotretinoin

Streamlined testing still overkill given lack of evidence for hepatotoxicity, pancreatitis

As GLP-1 Use Expands Into Dermatology, So Do the Medicolegal Implications

Off-label indications, use of compounded products could increase liability exposure

Risk of Paradoxical Hidradenitis Suppurativa in Psoriasis Varies by Biologic Agent

Infliximab and adalimumab had the highest risk, risankizumab and guselkumab the lowest

Dramatic Improvement in Dermatomyositis Skin Symptoms With First Approved Oral Agent

Lesion clearance rate, itch reduction doubled with TYK2/JAK1 inhibitor brepocitinib

Patient Develops Inflamed Rash After Double Mastectomy

Incision sites were itchy, painful, red, and oozing and were not showing signs of healing

AI System Faster but Not More Accurate Than Docs for Diagnosing Rheum Disease

Randomized trial tested Prof. Valmed, an EU-certified large language model

Autoimmune Events From Checkpoint Inhibitors Often Demand Aggressive Treatment

German study focused on cases referred to rheumatologists

Parasite Infestation Common in Eyelash Extensions, Study Suggests

Demodex folliculorum, skin irritation, blocked meibomian glands found frequently

Photodynamic Therapy for the Most Common Skin Cancer Wins Approval

Approach for superficial basal cell carcinoma may be ideal for cosmetically sensitive locations

FDA Warns of Serious Risks Tied to Misuse of Double-Chin Fat Dissolver

— Neuromuscular, vision effects reported after Kybella injection outside submental fat region

FDA Amps Up Warning on Kybella Adverse Events

An agency review cites new risks of nodules, masses, and numbness and weakness in the face.

US Regulators Urge More Research on Testosterone Therapy for Women as Experts Debate Benefits, Risks

US health regulators on Thursday called for more data on testosterone therapies for women, with FDA officials urging manufacturers to conduct studies that could support...

Pennsylvania Measles Cases Top 700 After Four Outbreak-related Deaths Reported

The Pennsylvania Department of Health on Wednesday reported 731 measles cases, up 38 from Monday's ⁠update, as the outbreak continued to spread in the state at the center of...

Latest News

Shingles Recurrence or Something Worse?

Bedside skin punch biopsy proved crucial

Skin Problems, Kidney Complaints, and Venous Issues Spike During Heat Waves

Study suggests attention to heat-related problems besides heat stroke

First Oral Option for Dermatomyositis Gets FDA Green Light

Brepocitinib significantly improved overall symptom status in a phase III trial

A Call to End Routine Laboratory Monitoring for Patients on Isotretinoin

Streamlined testing still overkill given lack of evidence for hepatotoxicity, pancreatitis

As GLP-1 Use Expands Into Dermatology, So Do the Medicolegal Implications

Off-label indications, use of compounded products could increase liability exposure

Risk of Paradoxical Hidradenitis Suppurativa in Psoriasis Varies by Biologic Agent

Infliximab and adalimumab had the highest risk, risankizumab and guselkumab the lowest

Dramatic Improvement in Dermatomyositis Skin Symptoms With First Approved Oral Agent

Lesion clearance rate, itch reduction doubled with TYK2/JAK1 inhibitor brepocitinib

Patient Develops Inflamed Rash After Double Mastectomy

Incision sites were itchy, painful, red, and oozing and were not showing signs of healing

AI System Faster but Not More Accurate Than Docs for Diagnosing Rheum Disease

Randomized trial tested Prof. Valmed, an EU-certified large language model

Autoimmune Events From Checkpoint Inhibitors Often Demand Aggressive Treatment

German study focused on cases referred to rheumatologists

Parasite Infestation Common in Eyelash Extensions, Study Suggests

Demodex folliculorum, skin irritation, blocked meibomian glands found frequently

Photodynamic Therapy for the Most Common Skin Cancer Wins Approval

Approach for superficial basal cell carcinoma may be ideal for cosmetically sensitive locations

FDA Warns of Serious Risks Tied to Misuse of Double-Chin Fat Dissolver

— Neuromuscular, vision effects reported after Kybella injection outside submental fat region

FDA Amps Up Warning on Kybella Adverse Events

An agency review cites new risks of nodules, masses, and numbness and weakness in the face.

US Regulators Urge More Research on Testosterone Therapy for Women as Experts Debate Benefits, Risks

US health regulators on Thursday called for more data on testosterone therapies for women, with FDA officials urging manufacturers to conduct studies that could support...

Pennsylvania Measles Cases Top 700 After Four Outbreak-related Deaths Reported

The Pennsylvania Department of Health on Wednesday reported 731 measles cases, up 38 from Monday's ⁠update, as the outbreak continued to spread in the state at the center of...

News All Time

US Regulators Urge More Research on Testosterone Therapy for Women as Experts Debate Benefits, Risks

US health regulators on Thursday called for more data on testosterone therapies for women, with FDA officials urging manufacturers to conduct studies that could support...

Fear of Relapse Burdens Patients With Vitiligo

Nearly half of patients with vitiligo who achieve repigmentation fear losing treatment gains, with relapse-related anxiety affecting psychological well-being even when skin improvement is maintained.

Adding IVIG to Prednisone Boosts Outcomes in IIMs

IVIG plus high-dose prednisone leads to improved disease activity and a faster response in newly diagnosed idiopathic inflammatory myopathies, but clotting remains a concern.

Smoke Exposure Tied to HS Risk in Children and Teens

Both passive and active exposure were associated with increased odds of diagnosis in pediatric and adolescent patients with hidradenitis suppurativa, a study reports.

A Decade After Mercury Ban, Toxic Skin Bleachers Still Offered on Top Retailers' Websites

(Removes errant quote marks in paragraph 14)

Pennsylvania Measles-associated Deaths Climb to Four as Outbreak Grows

The Pennsylvania Department of Health on Tuesday reported two more measles-associated deaths, both in unvaccinated individuals, bringing the state's total fatalities linked...

FDA Grants Priority Review to Zasocitinib for Psoriasis

Zasocitinib is also being evaluated in phase 3 studies for psoriatic arthritis and in phase 2 studies for Crohn’s disease, ulcerative colitis, vitiligo, and hidradenitis suppurativa.

Serious Infections Lower With Anifrolumab in CLE Patients

Anifrolumab, approved for systemic lupus, is currently being evaluated in a phase 3 study in patients with cutaneous lupus erythematosus.

COVID, 6 Years on: The Pandemic’s Long Clinical Shadow

Although acute COVID is generally less severe today, long COVID, limited treatment options, and ongoing controversy still define the pandemic’s aftermath.

Prior Keratinocyte Carcinoma Tied to Mucosal Melanoma

A history of keratinocyte carcinoma was associated with more than four times the odds of mucosal melanoma, study reports.

Trust in Measles Vaccines Falls in US, Reuters Ipsos Poll Finds

Americans' trust in vaccines for deadly childhood diseases including measles has fallen in recent years, a new Reuters/Ipsos poll found, a troubling sign for the country as...

Arizona Accuses L'Oreal Of Concealing Cancer Risks Linked to Hair Relaxers

Arizona has sued L'Oreal SA and its U.S. subsidiary, alleging the cosmetics company hid evidence that its hair relaxer products could cause cancer ⁠in women, as it faces...

Pembrolizumab Benefits Persist in Cervical Cancer

After 5 years of follow-up, pembrolizumab plus chemotherapy continues to demonstrate sustained survival advantages in patients with persistent, recurrent, or metastatic cervical cancer.

Combo Therapy May Help in Systemic Autoinflammatory Diseases

Patients with systemic autoinflammatory diseases refractory to standard treatments may show clinical improvements when treated with combinations of biologics and JAK inhibitors.

Criteria for Prescribing Testosterone: Who Qualifies?

A Brazilian multidisciplinary consensus sets thresholds for the diagnosis and treatment while emphasizing symptom assessment, repeated testing, and attention to the underlying causes.

Adjuvant Anti-PD-1 Boosts OS in Matched Melanoma Cases

Adjuvant anti-PD-1 therapy is tied to higher 5-year overall survival in patients with stage III melanoma in a matched analysis, but the population-level benefit remains unproven, a Danish study finds.

Recommended News For You

Adjuvant Radiation Boosts High-Risk Bladder Cancer Control

Anticoagulation for 12 months has been found to improve outcomes in cancer patients with minor blood clots.

Global warming could be driving up women's cancer risk, find researchers

Promising for Monitoring and Diagnosis of AD is the finger-prick test.

Alone for 500 Days, but Never Lonely: The Introvert's Dream.

Oncologist on Hantavirus Cruise; Bile Duct Cancer Drug OK'd; Untreated Lung Cancers

Losing a reward can affect your motivation and performance.

Recommended Articles For You

Prognostic Trajectories of Functional Recovery Following Major Hematologic Disorders 

Transformative Approaches in Hematology for Healthcare Excellence 

Degraders for Endocrine-Resistant Tumors: Mechanisms, Clinical Applications, and Emerging Therapeutic Strategies 

Screening for Early Therapy-Related Cancer Susceptibility 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Healthcare AI, Meant to Save Money, Turns Out to Require a Lot of Expensive Humans

2.

Beyond What Is Visible in Myelofibrosis?

3.

Race, Geography Linked to Gaps in Prostate Cancer Care

4.

Year in Review: Multiple Myeloma

5.

Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC

1.

Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer

2.

Patient Management Following Organ-Preserving Cancer Interventions

3.

Obesity is a major risk factor for cancer

4.

Innovative Pathways in Oncology Across Clinical Settings

5.

Integrated Frameworks in Hematology in Clinical Decision-Making

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI

2.

Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL

3.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

4.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I

5.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot